share_log

Methanex, Merck And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Benzinga ·  Sep 9 20:11

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 150 points on Monday.

Shares of Methanex Corporation (NASDAQ:MEOH) fell sharply in today's pre-market trading.

Methanex disclosed that it has entered into a definitive agreement to acquire OCI Global's international methanol business for $2.05 billion.

Methanex shares tumbled 6.3% to $39.79 in pre-market trading.

Here are some big stocks recording losses in today's pre-market trading session.

  • C4 Therapeutics, Inc.. (NASDAQ:CCCC) shares dipped 17% to $4.48 in pre-market trading. C4 Therapeutics will reveal preliminary CFT1946 monotherapy Phase 1 clinical data at ESMO Congress 2024.
  • Lotus Technology Inc. (NASDAQ:LOT) shares fell 5.4% to $4.90 in pre-market trading after gaining around 6% on Friday.
  • Merck & Co., Inc. (NYSE:MRK) fell 4.8% to $112.23 in pre-market trading. Daiichi Sankyo and Merck's Ifinatamab Deruxtecan showed response rates in extensive-stage small cell lung cancer in Phase 2 IDeate-Lung01 trial.
  • Mercer International Inc. (NASDAQ:MERC) shares declined 3.2% to $5.50 in pre-market trading. Adient will replace Mercer International in the S&P SmallCap 600.
  • Whitestone REIT (NYSE:WSR) shares fell 3.1% to $12.68 in pre-market trading.
  • QXO, Inc. (NASDAQ:QXO) fell 2.3% to $13.97 in pre-market trading after gaining over 4% on Friday.
  • Emergent BioSolutions Inc. (NYSE:EBS) shares slipped 2.3% to $7.34 in pre-market trading.

Now Read This:

  • S&P 500 Records Largest Weekly Decline Since March 2023 As Nvidia, Google Tumble: Fear & Greed Index Moves To 'Fear' Zone
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment